Priority sector
Healthcare & Medical Technologies
Healthcare products with clear pathways and real institutional buyers.
Our focus
We prioritize products and software that can enter the U.S. lawfully without speculative claims or disproportionate clinical and regulatory burden.
Potential U.S. buyers
Provider groups, telehealth organizations, hospitals, clinics, senior-living operators, specialty distributors, employers, and population-health programs.
Opportunity standard
The product must have a real buyer, a manageable U.S. pathway, manufacturer support, workable margins, and an open commercial role.
Examples we may consider
- Remote monitoring and healthcare software
- Wound-care and patient-support products
- Diagnostics with completed or clear pathways
- Workplace and institutional medical safety
- Workflow, compliance, and operational tools
Reasons we may decline
- Unclear medical claims
- Long, uncertain pivotal-trial requirements
- No manufacturer-controlled clinical support
- Reimbursement-dependent models without a defined path
- Products requiring Riddy Group to provide regulated clinical care
Start a conversation
Have a qualified healthcare & medical technologies product for the U.S.?
Start with product, company, current markets, U.S. activity, regulatory status, and the partnership you are seeking.
From sector fit to a defined pilot.
Explore our qualification process, regulatory-pathway coordination, or U.S. buyer and channel partnerships.